EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer

Published:2024-08 Issue:2 Volume:86 Page:164-182
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Tilki Derya,van den Bergh Roderick C.N.,Briers Erik,Van den Broeck Thomas,Brunckhorst Oliver,Darraugh Julie,Eberli Daniel,De Meerleer Gert,De Santis Maria,Farolfi Andrea,Gandaglia Giorgio,Gillessen Silke,Grivas Nikolaos,Henry Ann M.,Lardas Michael,J.L.H. van Leenders Geert,Liew Matthew,Linares Espinos Estefania,Oldenburg Jan,van Oort Inge M.,Oprea-Lager Daniela E.,Ploussard Guillaume,Roberts Matthew J.,Rouvière Olivier,Schoots Ivo G.,Schouten Natasha^ORCID,Smith Emma J.,Stranne Johan,Wiegel Thomas,Willemse Peter-Paul M.,Cornford Philip

Publisher

Elsevier BV

Reference158 articles.

1. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer;Cornford;Eur Urol,2021

2. Cornford et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2024 Apr 12:S0302-2838(24)02254-1. doi: 10.1016/j.eururo.2024.03.027. Online ahead of print. PMID: 38614820.

3. Going from evidence to recommendations;Guyatt;BMJ,2008

4. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?;Amling;J Urol,2001

5. Standardizing the definition of biochemical recurrence after radical prostatectomy—what prostate specific antigen cut point best predicts a durable increase and subsequent systemic progression?;Toussi;J Urol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives;Clinical Genitourinary Cancer;2024-10

2. Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics;BJU International;2024-09-11

3. Prostate Cancer’s Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism Manipulation;International Journal of Molecular Sciences;2024-08-27

4. Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients;World Journal of Urology;2024-08-12

5. Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer;Nature Reviews Urology;2024-08-07